Cantor Fitzgerald Starts EyePoint Pharmaceuticals, Inc. (EYPT) at Overweight
Cantor Fitzgerald analyst Jennifer Kim initiates coverage on EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) with an Overweight rating and price target ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)